167 related articles for article (PubMed ID: 31482507)
1. Understanding the Patient Perception of Statin Experience: A Qualitative Study.
Vrablik M; Catapano AL; Wiklund O; Qian Y; Rane P; Grove A; Martin ML
Adv Ther; 2019 Oct; 36(10):2723-2743. PubMed ID: 31482507
[TBL] [Abstract][Full Text] [Related]
2. Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.
Krüger K; Leppkes N; Gehrke-Beck S; Herrmann W; Algharably EA; Kreutz R; Heintze C; Filler I
Br J Gen Pract; 2018 Jun; 68(671):e401-e407. PubMed ID: 29686133
[TBL] [Abstract][Full Text] [Related]
3. The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy.
Jacobson TA; Cheeley MK; Jones PH; La Forge R; Maki KC; López JAG; Xiang P; Bushnell DM; Martin ML; Cohen JD
J Clin Lipidol; 2019; 13(3):415-424. PubMed ID: 31113745
[TBL] [Abstract][Full Text] [Related]
4. Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.
Jacobson TA; Edelman SV; Galipeau N; Shields AL; Mallya UG; Koren A; Davidson MH
Patient; 2017 Jun; 10(3):321-334. PubMed ID: 27981439
[TBL] [Abstract][Full Text] [Related]
5. LIFESTAT - Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction.
Christensen CL; Wulff Helge J; Krasnik A; Kriegbaum M; Rasmussen LJ; Hickson ID; Liisberg KB; Oxlund B; Bruun B; Lau SR; Olsen MN; Andersen JS; Heltberg AS; Kuhlman AB; Morville TH; Dohlmann TL; Larsen S; Dela F
Scand J Public Health; 2016 Jul; 44(5):534-9. PubMed ID: 26939591
[TBL] [Abstract][Full Text] [Related]
6. [Statin intolerance].
Graversen CB; Larsen ML; Schmidt EB
Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
[TBL] [Abstract][Full Text] [Related]
7. Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey.
Jacobson TA; Khan A; Maki KC; Brinton EA; Cohen JD
J Clin Lipidol; 2018; 12(1):78-88. PubMed ID: 29239815
[TBL] [Abstract][Full Text] [Related]
8. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).
Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640
[TBL] [Abstract][Full Text] [Related]
9. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
[TBL] [Abstract][Full Text] [Related]
10. A Clinical Guide to Combination Lipid-Lowering Therapy.
Russell C; Sheth S; Jacoby D
Curr Atheroscler Rep; 2018 Mar; 20(4):19. PubMed ID: 29516190
[TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.
Golomb BA; Kwon EK; Koperski S; Evans MA
Drug Saf; 2009; 32(8):649-61. PubMed ID: 19591530
[TBL] [Abstract][Full Text] [Related]
12. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
[TBL] [Abstract][Full Text] [Related]
13. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
[TBL] [Abstract][Full Text] [Related]
15. Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors.
Rane PB; Patel J; Harrison DJ; Shepherd J; Leith A; Bailey H; Piercy J
Am J Cardiovasc Drugs; 2018 Apr; 18(2):103-108. PubMed ID: 28849360
[TBL] [Abstract][Full Text] [Related]
16. Lipids: a personal view of the past decade.
Katsiki N; Mikhailidis DP
Hormones (Athens); 2018 Dec; 17(4):461-478. PubMed ID: 30229482
[TBL] [Abstract][Full Text] [Related]
17. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.
Calderon RM; Cubeddu LX; Goldberg RB; Schiff ER
Mayo Clin Proc; 2010 Apr; 85(4):349-56. PubMed ID: 20360293
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.
Sharma M; Ansari MT; Abou-Setta AM; Soares-Weiser K; Ooi TC; Sears M; Yazdi F; Tsertsvadze A; Moher D
Ann Intern Med; 2009 Nov; 151(9):622-30. PubMed ID: 19884623
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the prevalence of statin use in Germany - findings from national health interview and examination surveys 1997-1999 and 2008-2011].
Knopf HC; Busch MA; Du Y; Truthmann J; Schienkiewitz A; Scheidt-Nave C
Z Evid Fortbild Qual Gesundhwes; 2017 May; 122():22-31. PubMed ID: 28511896
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study.
Karalis DG; Wild RA; Maki KC; Gaskins R; Jacobson TA; Sponseller CA; Cohen JD
J Clin Lipidol; 2016; 10(4):833-841. PubMed ID: 27578114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
